- Curing Lights
- Finishing & Polishing
- Lesion Detection
- Oral Hygiene
- Soft Tissue Lasers
For the Treatment of Chronic Adult Periodontitis
ATRIDOX® (doxycycline hyclate) 10% is a major advancement in the treatment of periodontal disease. It is a locally applied antibiotic (LAA) that is placed gently below the gum line into periodontal pockets where bacteria thrive and cause infection.
ATRIDOX® is the only locally applied antibiotic gel that flows deeply into infected pockets.
ATRIDOX® is the only LAA that is clinically proven to achieve all three of the following outcomes in treating chronic adult peridontitis.
Only ATRIDOX® delivers unbeatable economics.
ATRIDOX® is an easy-to-use gel that is applied with a syringe into the infected tooth pocket. ATRIDOX® flows to the bottom of pockets and fills even the smallest spaces between teeth and gums. After ATRIDOX® is applied, it hardens upon contact with oral fluids (saliva) to a wax-like substance, and the antibiotic is slowly released into the surrounding infected tooth pocket.
In clinical studies, ATRIDOX® was generally well-tolerated. Side effects were similar to those of placebo. The most common side effects were: headache, common cold, gum discomfort, pain or soreness, toothache and tooth sensitivity. ATRIDOX® should not be used by patients who are hypersensitive to doxycycline or any other drugs in the tetracycline class. The use of drugs in the tetracycline class during tooth development may cause permanent discoloration of the teeth. Tetracycline drugs, therefore, should not be used in pregnant women, unless other drugs are not likely to be effective or are contraindicated.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visitwww.fda.gov/medwatch, or call 1-800-FDA-1088.
ATRIDOX® is clinically proven to increase clinical attachment when compared to scaling and root planing, oral hygiene or placebo.
The clinical attachment gain after nine months is 0.8 mm.
When compared to oral hygiene, or placebo, ATRIDOX® reduced probing depth caused by periodontitis. After nine months, ATRIDOX® reduced the probing depth by 1.2 mm.
ATRIDOX® was more effective than oral hygiene and placebo in reducing gum bleeding upon probing.2, 5
ATRIDOX® maintains sustained reduction of red complex bacteria over six months4
ATRIDOX® significantly reduced two of the most prevalent pathogens associated with periodontal disease, P. gingivalis and T. forsythia.
At three months, ATRIDOX® plus scaling and root planing substantially reduced P. gingivalis and T. forsythia.
P. gingivalis and T. forsythia combined were reduced by 82 percent compared to 33 percent for scaling and root planing alone.
Chart compares probing depth reduction at six months after scaling and root planing alone versus ATRIDOX® plus scaling and root planing.
ATRIDOX® plays an important role for the dental professional in Soft Tissue Management®.
As the DenMat product designed to treat chronic adult periodontitis, ATRIDOX® helps dental professionals tackle the disease and put it in reverse.
By incorporating this clinically proven antimicrobial within an oral-care program in the dental office, patients will appreciate improved comfort while the dental practice experiences improved patient outcomes.
Treatment type: newly diagnosed chronic adult periodontitis patient
Procedure code: D4381
CDT descriptor: Localized delivery of chemotherapeutic agents via a controlled release vehicle into diseased crevicular tissue, per tooth, by report.
When to use D4381:
1) Following evaluation after mechanical and surgical procedures (i.e. scaling and root planing, flap surgery, etc.); pockets > 5mm that demonstrate bleeding on gentle probing; scaling and root planing completed prior to ATRIDOX® administration
2) During routine periodontal maintenance visits
3) Uncommon situations (i.e. pre-existing medical condition) with detailed documentation
How to use:
NOTE: the D4381 procedure code permits the filing of a separate charge for each tooth being treated with ATRIDOX®. The fee for ATRIDOX® therapy should be per tooth.
D4381 is a procedure code that by definition is covered on a “by report” basis. Review of the claim by a dental claims examiner is likely. Therefore, it is important to support the decision to treat the patient in this manner with sufficient and legible clinical information.
Treatment type: maintenance patient
Procedure codes: D4910 plus D4381
When to use D4910 plus D4381:
1) During the maintenance appointment following scaling and root planing
2) After the completion of surgical or other definitive periodontal treatment therapies
3) During the same visit as periodontal maintenance
How to use:
Disclaimer: The reimbursement information contained here is provided to help you understand the reimbursement process. It is intended to assist providers in accurately obtaining reimbursement for dental health care services. It is not intended to increase or maximize reimbursement by any payer. We strongly suggest that you consult your payer organization with regard to local reimbursement policies. The information contained here is provided for information purposes only and represents no statement, promise or guarantee by DenMat, Inc., concerning reimbursement, payment or charge. Similarly, all CDT, CPT/HCPCS and ICD-9 codes are supplied for information purposes only and represent no statement, promise or guarantee by DenMat that these codes will be appropriate or that reimbursement will be made.
Products available for LSDP monthly product credit are indicated by this badge
Click for your LSDP Free Product Order Form